Challenges of treatment adherence in older patients with Parkinson's disease

Drugs and Aging

Volumn 26, Issue 2, 2009, Pages 145-155

  Bainbridge, Jacquelyn L ^a,c   Ruscin, J Mark ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Elderly; Parkinson's disease, treatment; Patient compliance

Indexed keywords

ANTIPARKINSON AGENT; NEUROPROTECTIVE AGENT;

COGNITIVE DEFECT; COMORBIDITY; DOCTOR PATIENT RELATION; ELDERLY CARE; HEALTH CARE COST; HUMAN; NEUROPSYCHIATRY; PARKINSON DISEASE; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME; TREATMENT REFUSAL;

AGED; AGED, 80 AND OVER; COMORBIDITY; DEPRESSION; HUMANS; MEMORY DISORDERS; PARKINSON DISEASE; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PHYSICIAN-PATIENT RELATIONS; POLYPHARMACY;

EID: 60249083468     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/0002512-200926020-00006     Document Type: Review

References (58)

1. MacLaughlin EJ, Raehl CL, Treadway AK, et al. Assessing medication adherence in the elderly: which tools to use in clinical practice? Drugs Aging 2005; 22 (3): 231-55
2. Playfer JR. The therapeutic challenges in the older Parkinson's disease patient. Eur J Neurol 2002; 9: 55-8
3. Grosset KA, Reid JL, Grosset DG. Medicine-taking behavior: implications of suboptimal compliance in Parkinson's disease. Mov Disord 2005; 20 (11): 1397-404
4. Grosset KA, Bone I, Grosset DG. Suboptimal medication adherence in Parkinson's disease. Mov Disord 2005; 20 (11): 1502-7
5. Leopold NA, Polansky M, Hurka MR. Drug adherence in Parkinson's disease. Mov Disord 2004; 19 (5): 513-7
6. Hughes CM. Medication non-adherence in the elderly: how big is the problem? Drugs Aging 2004; 21 (12): 793-811
7. Schlenk EA, Dunbar-Jacob J, Engberg S. Medication non-adherence among older adults: a review of strategies and interventions for improvement. J Gerontol Nurs 2004; 30 (7): 33-43
8. Morrell RW, Park DC, Kidder DP, et al. Adherence to antihypertensive medications across the life span. Gerontologist 1997; 37 (5): 609-19
9. Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 2002; 25 (6): 1015-21
10. Corden ZM, Bosley CM, Rees PJ, et al. Home nebulized therapy for patients with COPD: patient compliance with treatment and its relation to quality of life. Chest 1997 Nov 5; 112 (5): 1278-82
11. Salzman C. Medication compliance in the elderly. J Clin Psychiatry 1995; 56: 18-22
12. Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother 2004; 38 (2): 303-12
13. Nichol MB, Venturini F, Sung JCY. A critical evaluation of the methodology of the literature on medication compliance. Ann Pharmacother 1999; 33 (5): 531-40
14. Ranelli PL, Aversa SL. Medication-related stressors among family caregivers. Am J Hosp Pharm 1994; 51: 75-9
15. Stewart RB, Caranasos GJ. Medication compliance in the elderly. Med Clin North Am 1989; 73 (6): 1551-63
16. Balkrishnan R. Predictors of medication adherence in the elderly. Clin Ther 1998; 20 (4): 764-71
17. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001; 23 (8): 1296-310
18. Cramer J, Vachon L, Desforges C, et al. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial. Epilepsia 1995; 36 (11): 1111-7
19. Kruse W, Eggert-Kruse W, Rampmaier J, et al. Dosage frequency and drug-compliance behaviour: a comparative study on compliance with a medication to be taken twice or four times daily. Eur J Clin Pharmacol 1991; 41 (6): 589-92
20. Coleman EA. Falling through the cracks: challenges and opportunities for improving transitional care for persons with continuous complex care needs. J Am Geriatr Soc 2003; 51 (4): 549-55
21. Gray SL, Mahoney JE, Blough DK. Medication adherence in elderly patients receiving home health services following hospital discharge. Ann Pharmacother 2001; 35 (5): 539-45
22. Ruscin JM, Semla TP. Assessment of medication management skills in older outpatients. Ann Pharmacother 1996; 30 (10): 1083-8
23. Fargel M, Grobe B, Oesterle E, et al. Treatment of Parkinson's disease: a survey of patients and neurologists. Clin Drug Invest 2007; 27 (3): 207-18
24. Williams-Gray CH, Foltynie T, Lewis SJ, et al. Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options. CNS Drugs 2006; 20 (6): 477-505
25. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990; 150 (4): 841-5
26. Coons SJ, Sheahan SL, Martin SS, et al. Predictors of medication noncompliance in a sample of older adults. Clin Ther 1994; 16 (1): 110-7
27. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000; 160 (21): 3278-85
28. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160 (14): 2101-7
29. Chia LR, Schlenk EA, Dunbar-Jacob J. Effect of personal and cultural beliefs on medication adherence in the elderly. Drugs Aging 2006; 23 (3): 191-202
30. Garay-Sevilla ME, Malacara HJM, Gonzalez-Parada F, et al. The belief in conventional medicine and adherence to treatment in non-insulin-dependent diabetes mellitus patients. J Diabetes Complications 1998; 12 (5): 239-45
31. Neuman P, Strollo MK, Guterman S, et al. Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors. Health Aff (Millwood) 2007; 26 (5): w630-43
32. Scott MA, Jackson VL, Hitch WJ. Hospital admission associated with Medicare Part D "doughnut hole". Am J Health Syst Pharm 2007 May 15; 64 (10): 1029-30
33. Ridley DB, Axelsen KJ. Impact of Medicaid preferred drug lists on therapeutic adherence. Pharmacoeconomics 2006; 24: 65-78
34. Mind the gap: Medicare part D's coverage gaps may affect patient adherence. Am Fam Physician 2006 Feb 1; 73 (3): 404
35. Holley JL, DeVore CC. Why all prescribed medications are not taken: results from a survey of chronic dialysis patients. Adv Perit Dial 2006; 22: 162-6
36. Lynch T. Medication costs as a primary cause of nonadherence in the elderly. Consult Pharm 2006; 21 (2): 143-6
37. Nyholm D. Pharmacokinetic optimisation in the treatment of Parkinson's disease: an update. Clin Pharmacokinet 2006; 45 (2): 109-36
38. Rojo A, Aguilar M, Garolera MT, et al. Depression in Parkinson's disease: clinical correlates and outcome. Parkinsonism Related Disord 2003; 10 (1): 23-8
39. Liepelt I, Maetzler W, Blaicher HP, et al. Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors. Dement Geriatr Cogn Disord 2007; 23 (6): 351-67
40. Grosset KA, Bone I, Reid JL, et al. Measuring therapy adherence in Parkinson's disease: a comparison of methods. J Neurol Neurosurg Psychiatry 2006; 77 (2): 249-51
41. Grymonpre RE, Didur CD, Montgomery PR, et al. Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother 1998; 32 (7-8): 749-54
42. Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm 2003; 60 (7): 657-65
43. Higgins N, Regan C. A systematic review of the effectiveness of interventions to help older people adhere to medication regimes. Age Ageing 2004; 33 (3): 224-9
44. Huffman MH. Compliance, health outcomes, and partnering in PPS: acknowledging the patient's agenda. Home Healthcare Nurse 2005; 23 (1): 23-8
45. Stewart MA. Effective physician-patient communication and health outcomes: a review. CMAJ 1995; 152 (9): 1423-33
46. Lowe CJ, Raynor DK, Purvis J, et al. Effects of a medicine review and education programme for older people in general practice. Br J Clin Pharmacol 2000; 50 (2): 172-5
47. Cramer JA. Optimizing long-term patient compliance. Neurology 1995; 45 (2): S25-8
48. Bernsten C, Bjorkman I, Caramona M, et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care. Drugs Aging 2001; 18: 63-77
49. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990; 150: 1509-10
50. Sturgess IK, McElnay JC, Hughes CM, et al. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci 2003; 25: 218-26
51. Varma S, McElnay JC, Hughes CM, et al. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy 1999; 19: 860-9
52. Wu JY, Leung WY, Chang S, et al. Effectiveness of telephone counseling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomized controlled trial. BMJ 2006; 333: 552
53. Richter A, Anton SF, Koch P, et al. The impact of reducing dose frequency on health outcomes. Clin Ther 2003; 25 (8): 2307-35
54. Pahwa R, Factor SA, Lyons KE, et al. Practice parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review). Neurology 2006; 66: 983-95
55. Park DC, Morrell RW, Frieske D, et al. Medication adherence behaviors in older adults: effects of external cognitive supports. Psychol Aging 1992; 7 (2): 252-6
56. Orwig D, Brandt N, Gruber-Baldini AL. Medication management assessment for older adults in the community. Gerontologist 2006; 46: 661-8
57. Arbouw MEL, van Vugt JPP, Egberts TCG, et al. Pharmacogenetics of antiparkinsonian drug treatment: a systematic review. Pharmacogenomics 2007; 8 (2): 159-76
58. Poewe W. The need for neuroprotective therapies in Parkinson's disease: a clinical perspective. Neurology 2006 May 23; 66 (10 Suppl. 4): S2-9